Sacituzumab Tirumotecan Approval in China By
16 déc. 2024 05h19 HE
|
KuicK Research
Delhi, Dec. 16, 2024 (GLOBE NEWSWIRE) -- The recent approval of sacituzumab tirumotecan in China represents a significant advancement in oncology, particularly in the realm of targeted therapies....